Financial news, mergers and acquisitions, partnerships, and alliances.
Bioké has signed a number of recent distribution deals covering the the Netherlands, Belgium, and Luxembourg including ones with Syntec and Namocell.
NimaGen said that it will use the technology to develop and market new kits and panels for next-generation sequencing.
The firm has also begun an initiative to reduce and deliver sustainable revenue growth for 2019 to compensate for commercial challenges in the US market.
The firms originally inked the agreement in 2015 and have now extended it until 2025.
The partnership with Finnish medical data sciences services vendor MedEngine will help BC Platforms offer end-to-end services for pharma and health-tech companies.
Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.
Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.
A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.
In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.